Dicerna Pharma perks up ahead of NobelCon14 presentation; shares ahead 12% [Seeking Alpha]
Dicerna Pharmaceuticals, Inc. (DRNA)
Last dicerna pharmaceuticals, inc. earnings: 2/27 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.dicerna.com
Company Research
Source: Seeking Alpha
Dicerna Pharma perks up ahead of NobelCon14 presentation; shares ahead 12%Thinly traded micro cap Dicerna Pharmaceuticals (DRNA+12.2%) is up on triple normal volume. Shares have rallied23% this week.On Tuesday, January 30 CEO Douglas Fambrough, Ph.D., will deliver acorporate overview at NobelCon14 in Fort Lauderdale, FL. A live webcast will be accessible through the company's website.The company's lead candidate is DCR-PHXC, in Phase 1 development for primary hyperoxaluria, a group of rare inherited disorders that leads to kidney failure.Previously:Early-stage study underway assessing Dicerna's lead candidate in rare liver disorder (Dec. 7, 2017)See all stocks on the move »Now read:U.S. Biotech/Pharma Sector Daily Observations Letter: Jan. 18, 2018 »
Show less
Read more
Impact Snapshot
Event Time:
DRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DRNA alerts
High impacting Dicerna Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics